A Study of Belzutifan in Adolescent Participants With Solid Tumors (MK-9999-01E/LIGHTBEAM-U01)

Clinical trial NCT07700758 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07700758
Sponsor: Merck Sharp & Dohme LLC
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Malignant Neoplasm

Start date: 2026-11-23
Primary completion: 2034-01-02
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.